Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea139ad438b9ce7d33159d45b154c6b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-34022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8257 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08 |
filingDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326d84f4b2f47cd59cc67c92fc9ce587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6714cb9d165aae26f6be01d8a0e3fab5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2d11d970e3d0e64f4667376ac4455e |
publicationDate |
2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0200169-A2 |
titleOfInvention |
Production of vaccines using transgenic plants |
abstract |
Plants infected with potato virus Y (PVY) were inoculated with infectious PVX RNA encoding PVX coat protein (CP) and modified chimeric NDV/BYMV CP. Antigen-coated plate indirect ELISA and immunoelectron microscopy of virus purified from infected plants showed that progeny virions contained from <1% to as much as 25% chimeric CP. The method can be used to produce and purify large amounts of NDV vaccine. Transencapsidated PVY virions expressing NDV were purified and used to induce anti-NDV antibodies in mice. Further, transgenic tobacco plants expressing HIV/BYMV CP were inoculated with BYMV. Progeny virions from transgenic plants contained transgenic HIV/BYMV CP. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051571-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068219-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009048354-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10047388-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9080215-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006004648-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100393870-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9382537-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377450-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644241-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7132291-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108315493-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2272525-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1732615-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7641896-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004098533-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10655184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004004761-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1732615-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0200169-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109486992-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109486992-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447414-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8282940-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339535-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008058369-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101189-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9365852-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9506061-B2 |
priorityDate |
2000-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |